2020 MELANOMA - MCKEAN - Combination Immunotherapy vs Monotherapy for Metastatic Melanoma

dbrock's picture
GRACE Videos and Articles
GRACE is excited to bring you a new series on current updates in Melanoma Treatment

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.   

In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma.


A huge thank you to our sponsor, Merck!


To join the conversation, visit https://cancergrace.org/forum​.



Video Language: 


Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation